TSS:Rfhg 125388.1

Basic information about the TSS

---

TSS ID: rfhg_125388.1 Species: human Chr: chr10		Start: 50623386 End: 50623417 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2343046,EH38E1467542)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: KX061767:226 GeneID: 259230 HGNC/MGI_ID: HGNC:29799 UniProt_ID: Nearer transcript ids and distances:

Gene_name: SGMS1 Gene_symbol: SGMS1 Gene_synonyms: MGC17342 MOB SMS1 Gene_source: HGNC:29799

TATA-Box annotation

---

Distance to TSS:	555
Nearest PromoterID:	NM_147156
Entrez ID:	259230
Nearest Unigene:	Hs.654698
Nearest Refseq:	NM_147156
Nearest Ensembl:	ENSG00000198964
Gene Name:	SGMS1
Gene Alias:	MOB|MOB1|SMS1|TMEM23|hmob33
Gene Type:	protein-coding
CpG%:	0.032258
GC%:	0.562500
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SGMS1 p2@SGMS1 p3@SGMS1 p4@SGMS1 p5@SGMS1 p6@SGMS1
Sample		p1@SGMS1	p2@SGMS1	p3@SGMS1	p4@SGMS1	p5@SGMS1	p6@SGMS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	7.99	0.97	2.14	0.39	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.70	1.82	3.44	0.00	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.94	2.89	2.12	0.39	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.03	1.87	2.08	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.45	1.57	1.57	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.98	2.52	1.55	0.19	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.46	1.53	0.87	0.00	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.02	1.45	1.45	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.77	1.92	1.07	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	1.74	1.74	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.49	1.62	2.02	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.13	2.03	3.25	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.99	0.32	0.32	0.32	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.47	0.00	0.15	0.00	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.42	0.88	0.00	0.22	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.29	0.50	0.00	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.86	0.87	0.00	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.37	0.84	0.84	0.42	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.33	0.00	1.07	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.67	0.60	0.45	0.45	0.15	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.49	0.67	0.13	0.67	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.18	0.69	0.17	0.35	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.92	0.90	0.13	0.52	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.82	0.24	0.24	0.00	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.51	0.77	0.26	0.00	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	1.27	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	0.55	0.00	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.54	0.47	0.47	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.46	0.65	0.16	0.48	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.32	1.27	0.00	0.36	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	0.42	0.84	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.18	0.00	0.00	0.20	0.20	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.23	0.42	0.00	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.08	0.33	0.16	0.49	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.85	0.37	0.19	0.19	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.47	0.57	0.38	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.34	0.82	0.00	0.20	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.24	0.60	0.20	0.00	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	1.08	0.27	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	5.52	0.24	0.72	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.82	1.65	0.47	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.39	0.73	0.15	0.00	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.27	1.69	0.42	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	4.20	2.10	0.70	0.00	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.02	0.80	0.60	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.89	0.93	1.16	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.08	1.20	1.20	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.28	1.49	0.00	0.30	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	3.35	1.44	0.48	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	1.62	0.40	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	0.61	0.61	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.89	1.11	0.89	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.90	1.06	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.98	0.33	0.00	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	0.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.21	0.46	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.86	1.62	0.65	0.00	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.50	0.64	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	0.31	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.12	2.12	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2.80	0.56	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	0.80	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.78	1.36	0.34	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.87	0.65	0.32	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	0.71	0.35	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	1.95	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.45	1.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.69	1.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	8.28	0.33	0.00	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.50	1.86	0.93	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	0.92	0.31	0.31	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	4.75	11.72	1.43	0.16	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	4.49	8.66	2.09	0.48	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	5.98	13.23	1.78	0.00	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	10.46	11.96	0.75	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	4.02	9.04	1.34	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	6.38	6.38	2.55	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	0.00	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1.35	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.00	0.17	0.70	0.17	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	17.41	3.91	1.37	0.59	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	7.46	2.57	0.77	1.03	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	14.77	5.02	1.39	0.28	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	2.94	1.76	0.59	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.53	4.18	1.21	0.80	0.48	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	15.49	3.23	2.26	1.61	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	11.20	4.27	1.60	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	7.79	2.23	0.56	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	5.41	2.50	1.25	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	9.80	4.27	1.76	0.25	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	3.93	3.27	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.92	1.83	2.44	0.30	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	4.64	7.07	1.33	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.43	5.02	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.71	14.75	0.90	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.73	9.04	0.41	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.61	4.00	1.60	0.11	1.37	0.00
Anulus Pulposus Cell, donor2	11463-119B5	5.39	3.18	0.49	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	3.59	0.00	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	1.30	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	0.00	4.28	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	2.99	1.20	0.90	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	1.26	1.26	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	0.66	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.57	1.62	0.32	0.65	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	0.00	0.00	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	0.59	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.90	0.75	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	1.25	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	3.95	1.65	0.99	0.49	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.22	1.51	0.75	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.75	0.54	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.59	1.51	0.94	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.08	0.27	0.80	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	2.93	2.93	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	2.49	1.49	0.66	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	3.60	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.09	1.20	0.34	0.17	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	3.88	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	3.04	2.28	0.00	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.42	0.00	0.57	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.49	1.28	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.61	0.52	0.77	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	0.94	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	0.96	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	0.00	0.00	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.34	0.00	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.42	0.30	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1.19	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	0.00	1.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.86	0.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	1.27	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.45	0.86	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	3.60	0.64	0.42	0.42	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.48	0.87	0.87	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	0.94	1.89	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.92	1.53	0.51	0.17	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	3.65	0.86	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	0.60	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1.46	1.46	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.06	0.69	0.23	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.81	2.54	0.76	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.34	1.24	0.62	0.00	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.14	0.61	0.31	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	0.48	0.48	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.77	0.44	0.22	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.77	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.56	0.00	0.53	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.63	0.36	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	4.42	2.58	0.61	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	4.62	2.91	0.86	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	2.94	0.42	1.05	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	12.55	1.74	0.35	0.35	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	7.44	2.91	1.29	0.65	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	8.35	3.13	0.45	0.15	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.45	12.62	8.14	0.69	0.11	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	19.92	15.91	7.27	1.25	0.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.30	13.09	5.80	0.68	0.00	1.14
Basophils, donor1	12241-129G9	13.34	17.78	3.14	0.26	0.52	0.78
Basophils, donor2	12242-129H1	25.26	32.11	4.69	0.36	1.08	1.08
Basophils, donor3	12243-129H2	11.76	26.61	5.59	0.73	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	1.94	0.43	0.00	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	1.83	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.14	3.77	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	5.20	4.16	0.42	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.68	2.30	0.23	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	9.90	5.76	1.08	0.36	0.00	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.97	1.75	2.89	0.41	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.72	6.99	9.08	0.93	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.67	0.32	0.32	1.60	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	26.49	92.99	17.47	1.13	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	15.78	67.56	16.33	0.56	0.00	3.90
CD14+ Monocytes, donor3	11381-118B4	19.54	59.27	14.71	0.66	0.66	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	50.10	100.48	43.87	2.83	2.26	2.55
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	50.80	75.44	28.43	1.90	1.90	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	53.26	113.74	33.20	0.33	0.66	2.63
CD14+ monocytes - mock treated, donor1	11863-125A9	16.62	49.87	12.72	0.43	0.14	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	14.48	33.80	8.15	0.30	0.60	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	20.14	52.35	11.84	0.24	0.71	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.54	81.69	25.44	0.33	0.17	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.66	65.41	17.94	0.83	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.41	119.01	28.51	0.50	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.20	116.31	34.07	0.39	0.00	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.33	89.02	22.43	0.71	0.18	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.01	136.45	26.99	0.44	0.44	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.28	157.33	50.10	0.00	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.26	122.50	35.91	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	153.09	42.16	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.73	71.70	20.53	0.45	0.15	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.38	52.68	8.58	0.80	0.40	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	72.45	11.03	0.00	0.62	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.61	175.71	37.75	0.23	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.22	132.33	21.04	0.68	0.23	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	11.78	141.41	32.30	0.44	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	10.49	57.29	18.83	0.54	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.65	68.56	19.02	0.52	0.17	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.99	83.74	19.36	0.84	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.72	162.58	34.91	0.00	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.98	104.27	20.43	0.00	0.35	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.09	159.70	28.08	0.00	0.44	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	103.75	33.83	0.17	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	69.13	19.70	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.21	140.11	27.59	0.22	0.65	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	12.28	131.04	37.26	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.20	121.00	17.62	0.00	0.46	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.58	167.03	25.98	0.23	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	13.30	7.41	2.18	0.65	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	14.09	13.40	2.31	0.69	0.00	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	12.78	7.58	1.95	0.22	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	25.54	29.59	8.72	0.78	0.16	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	21.66	26.55	8.21	0.52	0.52	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	36.34	26.31	9.59	0.67	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	13.52	6.12	1.53	0.77	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	12.08	10.32	1.98	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	15.58	6.95	1.47	1.05	0.00	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	52.84	2.03	2.03	4.06	0.00	10.16
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.85	2.71	0.00	2.03	1.36	3.39
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	2.07	1.04	0.00	2.07	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	67.16	2.13	2.13	2.13	0.00	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	48.25	1.07	0.00	3.75	0.00	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	47.73	2.11	1.40	4.21	0.70	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.12	2.35	0.78	2.35	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	59.32	3.95	0.00	2.64	1.32	5.27
CD19+ B Cells, donor1	11544-120B5	51.78	0.82	0.82	2.47	0.82	4.11
CD19+ B Cells, donor2	11624-122B4	37.72	1.45	2.18	1.45	1.45	2.90
CD19+ B Cells, donor3	11705-123B4	36.35	3.03	1.51	3.53	1.01	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	57.38	50.91	2.83	4.85	6.06	7.68
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	41.15	43.54	4.79	7.59	4.79	5.99
CD34+ Progenitors, donor1	11545-120B6	17.07	0.00	1.00	1.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	18.54	15.17	1.12	0.00	1.12	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.79	2.63	1.13	1.13	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.91	2.48	0.45	1.13	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	53.92	11.07	12.85	3.57	1.43	5.71
CD4+ T Cells, donor2	11306-117C1	34.29	6.74	13.47	1.84	0.00	4.90
CD4+ T Cells, donor3	11382-118B5	45.14	25.01	23.48	2.44	0.61	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.52	5.62	4.08	2.30	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.91	6.74	4.72	3.14	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.15	9.77	4.02	1.72	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	56.89	3.32	0.47	1.90	0.95	5.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	59.00	1.40	2.11	4.92	0.70	4.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.69	6.21	5.35	0.87	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.05	11.02	12.88	1.36	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.74	12.74	10.32	0.81	0.00	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	49.76	126.87	64.55	4.03	0.45	5.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	66.03	110.76	76.52	3.84	2.45	5.24
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	89.32	109.12	43.56	4.40	2.64	10.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.66	0.84	0.84	1.69	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.49	1.25	1.87	1.45	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.70	0.33	0.33	1.34	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.93	0.00	0.27	3.81	0.27	4.08
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.99	0.00	0.00	4.82	1.07	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	0.00	0.00	3.59	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	16.50	4.26	4.08	1.11	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	16.90	5.42	2.82	0.65	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	14.08	4.62	4.20	1.26	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	41.46	3.54	1.01	2.53	0.51	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	52.86	3.03	4.33	1.30	0.43	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	51.86	3.49	0.44	3.49	0.87	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	57.90	1.48	0.00	2.47	0.00	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	52.62	0.92	0.92	4.62	0.92	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	51.65	0.00	2.79	1.40	4.19	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	71.45	2.77	0.55	2.77	0.83	5.54
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	76.81	1.47	0.00	3.44	0.74	4.91
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	1.54	4.62	1.54	1.54	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	57.30	2.15	1.43	2.51	0.00	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	1.38	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	44.53	0.98	1.64	1.64	0.98	5.24
CD8+ T Cells, donor2	11307-117C2	22.15	2.25	3.00	0.38	1.13	6.01
CD8+ T Cells, donor3	11383-118B6	45.20	1.77	3.28	1.01	0.50	4.04
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.09	19.27	2.52	0.00	0.69	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.78	20.37	2.64	0.24	0.72	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.58	15.59	3.56	0.55	0.27	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.11	18.01	4.50	0.30	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.44	24.48	2.88	0.72	0.72	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.37	21.60	1.36	0.45	1.14	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	13.47	24.55	3.04	0.00	0.22	3.04
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.58	24.48	3.42	1.05	0.79	2.90
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.49	26.03	2.58	0.47	0.47	4.92
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	10.26	23.24	2.72	0.00	0.30	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	12.49	27.02	3.78	0.58	0.29	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.59	26.38	2.93	1.33	0.53	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.51	15.76	1.75	0.44	1.31	6.13
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.30	17.31	1.37	1.37	1.82	8.20
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	12.68	2.98	0.75	0.75	10.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.97	24.49	2.88	1.08	0.36	3.96
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.39	25.61	2.01	0.58	0.86	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.56	27.11	1.65	0.94	0.71	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.41	24.08	1.58	0.32	0.95	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.38	23.68	2.46	0.62	0.31	2.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	21.48	2.89	0.32	0.96	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.09	24.10	1.91	0.38	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.37	18.92	1.58	0.39	0.79	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	28.74	3.78	0.00	0.00	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	14.45	12.85	0.00	1.61	2.41	8.83
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	21.68	24.48	5.60	0.00	2.80	12.59
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	25.04	7.01	1.00	4.01	11.02
Cardiac Myocyte, donor1	11525-119I4	20.11	0.00	0.00	0.00	3.66	1.83
Cardiac Myocyte, donor2	11605-120I3	8.40	2.96	0.99	0.99	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	7.89	6.31	0.84	0.53	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	9.01	12.48	0.35	1.04	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.55	5.69	0.36	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	10.01	9.78	1.59	0.11	0.57	0.46
Chondrocyte - re diff, donor2	11339-117F7	15.22	9.85	1.79	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	9.30	4.45	0.81	1.21	1.21	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	9.75	1.72	0.92	0.46	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	5.77	0.86	0.43	0.64	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	10.18	1.68	0.71	0.62	0.18	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.75	8.44	4.77	1.47	2.84	1.74
Corneal Epithelial Cells, donor1	11526-119I5	3.95	1.98	0.22	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	5.62	4.60	0.77	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.46	2.81	1.98	0.50	0.17	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.66	3.15	1.26	0.00	0.32	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	3.45	3.45	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	10.37	3.02	1.62	0.43	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.25	2.73	1.02	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	12.40	2.61	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	1.94	0.00	1.94	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	8.17	2.50	1.33	0.50	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	0.59	0.59	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.20	2.26	1.98	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	8.65	1.57	1.57	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	3.78	0.87	0.87	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	5.41	2.12	2.35	1.18	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	5.08	2.63	2.98	0.53	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.86	1.55	1.99	0.66	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.60	1.52	3.04	0.00	0.30	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.40	0.85	3.10	1.13	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	2.08	2.08	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	5.73	5.73	4.69	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	5.96	3.12	2.41	0.71	0.43	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	11.20	1.60	2.40	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	0.52	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.79	3.35	2.86	0.87	0.25	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.34	1.30	2.61	0.43	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.46	3.66	4.40	1.59	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	0.70	2.79	0.70	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	6.44	1.57	1.57	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	4.95	0.00	0.00	4.95	28.05
Eosinophils, donor3	12246-129H5	53.50	0.00	0.00	0.00	3.57	24.97
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	2.44	0.98	0.49	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	5.34	9.44	0.82	0.41	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.75	0.88	0.44	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.12	1.30	0.43	0.22	0.43	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	6.43	7.40	1.94	0.49	0.24	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	16.65	8.32	1.64	0.14	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	6.01	3.38	1.05	0.21	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.98	6.32	0.00	0.53	2.37	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.96	5.32	1.66	0.00	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	3.63	4.54	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	0.00	1.52	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	2.21	0.63	0.32	0.16	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	14.85	8.18	1.82	0.91	1.52	0.61
Fibroblast - Cardiac, donor5	11456-119A7	14.59	5.33	1.40	0.25	0.63	0.13
Fibroblast - Cardiac, donor6	11460-119B2	11.82	4.70	1.06	0.76	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.33	1.34	0.27	0.13	0.67	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.06	3.02	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	1.46	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	2.08	0.00	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	8.82	2.71	1.53	0.51	2.37	0.17
Fibroblast - Dermal, donor1	11269-116G9	4.46	0.94	0.23	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.19	0.94	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	3.02	2.78	0.24	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	6.90	6.56	1.47	0.79	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	11.51	8.55	1.22	0.52	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	9.58	6.66	0.81	0.81	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	10.83	1.25	0.42	0.00	1.04	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.98	12.58	1.31	1.05	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	6.72	3.82	0.92	0.66	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	14.50	2.03	0.58	0.48	1.06	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	2.08	0.00	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.86	3.00	0.88	0.70	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	7.17	7.64	0.94	0.62	1.25	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	9.06	7.57	0.54	0.54	0.41	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.47	10.23	2.12	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	12.14	4.97	1.61	0.15	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	7.77	6.00	1.09	0.68	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.21	9.43	1.65	0.88	0.11	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.89	6.75	0.44	0.73	1.91	0.29
Fibroblast - Lung, donor1	11270-116H1	2.72	4.08	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	5.97	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	2.74	2.11	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	11.66	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.84	0.84	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	6.50	9.34	1.22	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	8.34	4.46	0.97	0.78	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	8.95	6.07	2.43	0.46	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.52	9.18	1.53	0.92	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.98	4.20	1.14	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.99	9.18	1.89	1.08	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.42	3.60	1.16	0.93	0.46	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	6.96	6.08	1.99	0.00	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3.66	6.30	1.22	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	3.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1.98	1.19	1.19	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.88	23.62	1.39	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.05	5.33	1.07	0.18	1.42	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.20	9.46	2.17	0.79	0.79	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.73	15.95	0.60	0.00	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.03	9.39	1.08	0.76	0.86	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.21	11.14	1.52	0.00	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	9.52	7.88	1.31	0.00	0.98	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	11.43	24.86	5.21	0.60	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	8.04	7.13	1.31	0.40	0.70	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.23	12.69	0.30	0.00	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.65	8.53	1.08	0.91	1.91	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.22	7.35	0.68	0.85	3.42	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.45	13.47	1.97	0.33	0.66	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	10.97	10.87	1.17	0.53	0.21	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	7.25	5.57	1.52	0.00	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.65	3.61	0.16	0.16	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	16.56	3.49	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.44	5.89	1.39	0.17	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.40	12.49	1.30	1.04	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.86	7.15	1.53	0.51	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.89	0.00	0.77	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.93	3.19	0.64	1.28	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	24.25	0.00	0.57	2.28	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.68	0.00	0.55	0.55	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.05	0.00	0.46	1.14	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	19.61	2.97	0.00	1.19	0.79	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.84	0.00	0.26	0.79	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	15.00	0.98	0.33	3.26	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	33.17	2.21	0.88	2.21	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	15.55	0.28	0.00	0.71	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	13.79	0.49	0.12	1.35	0.49	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	12.63	0.54	0.00	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	4.46	1.98	1.12	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	5.26	3.74	0.97	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	3.46	4.47	1.63	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.53	0.91	0.23	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	5.73	0.50	0.37	0.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.43	3.28	0.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.39	0.59	0.30	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	9.70	0.48	0.16	0.79	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	9.16	0.45	0.22	0.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	6.65	0.00	0.40	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.84	0.51	0.17	1.02	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	9.84	2.93	1.15	0.44	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.01	0.42	0.00	0.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.37	0.00	0.00	0.51	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.85	0.00	0.11	0.22	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.57	1.41	0.75	0.33	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.21	1.84	0.61	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	4.75	0.00	0.00	0.21	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.65	0.35	0.12	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.00	0.17	0.17	0.33	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	3.97	0.00	0.22	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	7.63	0.12	0.25	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	7.62	0.65	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.12	0.00	0.09	0.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5.38	0.00	0.16	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	3.65	0.00	0.00	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	5.85	0.21	0.21	0.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	4.83	0.00	0.00	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.17	1.12	0.00	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.46	0.19	0.28	0.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	4.55	0.27	0.00	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	4.59	0.31	0.61	0.00	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	5.96	0.13	0.26	0.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	4.88	0.00	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	3.32	0.18	0.74	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	3.73	0.00	0.44	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	3.96	0.40	0.79	0.26	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	6.05	1.01	0.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	7.88	2.54	0.76	0.51	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	24.68	1.00	0.00	3.38	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	21.26	0.46	0.31	1.54	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.94	0.00	0.20	1.84	0.20	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.39	0.00	1.56	0.63	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.91	0.28	0.28	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.14	0.00	0.00	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.90	0.39	0.39	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	3.21	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	10.42	0.98	0.00	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.82	0.41	0.00	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.07	1.12	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	10.13	1.31	0.00	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	0.84	0.00	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.59	1.91	0.64	0.95	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.49	1.70	1.02	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	0.57	0.00	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.22	0.30	0.59	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	6.78	0.00	0.00	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.98	2.07	2.49	0.83	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	9.44	0.92	0.69	0.23	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	8.84	1.54	1.15	0.38	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.71	2.61	0.98	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	0.67	2.01	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	14.25	1.16	1.54	1.16	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.01	7.53	1.71	0.68	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	13.21	0.00	0.94	0.94	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	11.47	0.60	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	18.82	1.53	0.51	1.02	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	0.80	0.40	1.99	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.16	1.97	0.49	0.99	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	0.00	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.67	0.00	0.58	2.33	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	17.99	0.44	0.00	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	0.00	0.00	0.00	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	0.60	0.00	1.79	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.68	1.94	0.49	0.49	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	2.28	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.91	5.41	0.00	0.00	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	5.62	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.17	5.71	0.63	0.63	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	2.09	0.84	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	3.48	13.23	2.09	0.81	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.70	16.71	1.86	0.51	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	3.64	13.42	2.05	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.17	15.96	2.95	0.22	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.22	12.04	1.50	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.66	16.36	2.15	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	3.86	11.58	2.74	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.26	9.61	1.03	0.34	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.56	9.61	1.92	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	1.12	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.30	2.16	1.30	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	7.05	0.71	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.18	1.45	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.37	5.94	1.75	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	32.69	2.42	2.42	1.21	4.84	0.00
Hepatocyte, donor2	11603-120I1	26.93	5.39	3.23	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	36.20	0.61	1.23	3.68	2.45	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	10.44	0.00	0.00	2.61	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	20.80	13.11	3.50	0.87	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.49	0.96	0.55	0.27	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	31.84	6.37	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	26.70	13.35	6.68	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	27.69	4.15	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	25.03	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	43.57	17.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	41.14	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	51.98	12.99	4.87	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	23.34	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	10.89	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	54.26	9.26	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	16.63	7.76	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	31.43	5.24	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	32.12	3.78	1.89	0.63	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	20.11	4.64	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	22.61	9.69	1.94	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	28.98	4.83	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	30.15	10.59	2.44	0.81	7.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	12.59	24.77	6.30	0.84	0.42	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	25.72	2.41	0.00	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	14.77	7.39	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.44	18.41	2.83	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	15.42	2.72	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	18.29	3.23	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	20.33	3.81	0.00	2.54	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	6.38	27.42	3.19	1.91	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	23.69	5.47	3.65	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	17.14	4.28	2.14	0.71	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	19.91	3.32	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.19	14.82	5.25	0.93	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	19.32	7.02	0.00	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	22.00	6.29	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.78	30.60	6.26	4.17	0.00	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	24.34	8.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	29.18	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.05	28.77	6.10	2.62	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	24.75	9.00	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	13.94	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	17.07	24.54	1.07	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	34.64	4.16	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	28.50	5.70	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	45.10	7.36	0.92	0.92	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	24.20	0.00	0.00	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	24.83	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	19.03	2.11	2.11	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	5.88	2.37	0.82	0.24	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	2.93	1.76	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.58	6.06	1.33	0.19	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	19.98	6.47	1.25	0.45	0.23	0.79
Keratocytes, donor1	11527-119I6	11.00	1.38	0.00	0.34	0.00	1.03
Keratocytes, donor2	11607-120I5	5.86	1.17	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	7.90	0.59	0.20	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	10.99	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2.16	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	11.76	0.92	0.81	0.69	0.46	0.12
Lens Epithelial Cells, donor3	11690-122I7	13.12	2.52	1.11	0.40	0.50	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.74	1.54	1.30	0.36	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.35	0.56	0.28	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.19	1.26	2.52	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	2.15	1.08	1.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	1.26	0.63	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.13	0.43	1.73	0.11	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	3.69	2.05	1.23	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.77	0.00	0.76	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.24	0.56	1.69	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.33	1.98	1.19	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.10	0.97	1.36	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.67	0.37	1.48	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	1.05	3.48	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.10	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.20	0.14	1.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.54	1.23	1.85	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.56	0.62	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.66	0.73	0.91	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1.97	1.65	1.65	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.46	0.88	1.17	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.49	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	2.42	0.48	0.97	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	2.69	0.54	1.35	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.82	0.61	1.67	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	0.52	0.00	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.98	1.05	1.68	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	0.45	1.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	2.75	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	1.88	0.75	2.07	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.44	0.74	1.06	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	0.97	0.97	2.91	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.32	0.33	0.99	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.60	0.37	1.24	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.40	1.48	1.11	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.47	2.47	1.98	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.20	0.55	0.96	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.75	2.25	1.61	0.00	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.17	0.91	1.83	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3.92	1.12	2.52	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	3.56	1.78	2.84	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.97	0.48	1.94	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.24	0.62	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	2.51	0.36	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	1.31	1.63	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.65	0.24	1.88	0.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.30	0.50	1.61	0.50	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	0.51	0.77	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.49	0.30	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	6.80	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	10.74	3.07	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	12.62	3.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	18.62	6.35	0.85	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	11.96	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	10.27	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	11.85	4.64	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	17.84	3.57	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.50	11.99	3.39	0.23	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.38	16.29	2.62	0.58	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	18.46	3.60	1.35	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.97	19.65	4.47	0.81	0.00	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	12.32	14.89	3.08	1.03	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.00	12.70	3.18	0.71	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	9.33	2.00	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	16.30	3.57	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.27	15.74	3.74	1.33	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.74	15.30	4.91	0.94	0.19	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.11	13.50	3.07	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	18.75	6.52	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.70	19.37	5.21	1.04	0.21	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.61	19.90	5.04	1.12	0.28	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	18.55	13.39	4.12	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	10.16	16.26	2.03	1.74	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.54	26.60	5.98	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	14.38	16.04	4.98	1.66	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.85	18.03	4.24	1.06	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	20.65	4.06	0.74	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	11.51	4.61	3.45	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.28	20.34	3.84	0.38	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	14.72	6.23	2.26	0.00	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	16.41	3.28	0.00	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.94	21.24	3.16	0.45	0.45	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	15.80	1.44	0.00	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	20.91	2.99	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.01	10.40	3.34	2.60	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	18.52	2.15	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	9.42	3.43	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.66	14.66	4.00	0.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	15.69	3.02	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13.51	19.91	2.84	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.56	18.22	2.06	1.03	0.34	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	10.20	4.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	12.79	2.02	0.00	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	11.85	14.08	3.33	0.74	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	6.98	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	11.64	5.29	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.40	17.21	4.00	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	20.35	5.81	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	10.73	13.80	3.07	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	21.21	1.48	0.00	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	14.11	4.70	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.09	14.58	3.02	1.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	11.27	0.45	0.45	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	10.33	1.72	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.02	18.26	6.23	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	19.94	3.13	0.39	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	13.19	5.28	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.90	15.05	4.67	1.04	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.00	18.82	3.50	1.31	0.44	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	23.48	4.47	0.56	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.90	22.52	3.09	0.88	0.88	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.41	18.90	5.40	1.16	0.00	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.14	23.80	6.58	0.51	2.03	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	17.30	4.81	0.96	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.93	14.71	6.76	1.99	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	23.70	1.82	0.00	0.61	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	12.45	28.36	1.38	1.38	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	20.90	5.32	2.66	0.00	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	15.49	6.20	0.52	0.52	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	15.72	18.14	3.63	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.68	17.75	6.34	2.85	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.33	22.39	4.80	0.00	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	23.56	1.72	0.57	0.00	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.83	30.34	5.66	1.54	0.00	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	29.00	9.20	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.92	24.97	0.57	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13.73	17.06	4.16	1.25	0.00	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	18.01	2.35	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	17.12	1.67	0.00	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.87	19.51	3.25	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	18.06	3.35	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	16.57	0.53	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	15.76	1.62	2.42	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	14.68	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	11.56	0.00	1.78	0.00	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	14.82	2.85	1.14	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	11.50	15.34	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	15.87	2.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.35	10.25	4.01	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.34	13.26	4.16	2.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	10.61	15.25	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	12.47	10.39	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.45	88.89	26.44	1.37	0.68	1.60
Macrophage - monocyte derived, donor2	11313-117C8	13.95	11.93	4.04	1.47	0.18	0.92
Macrophage - monocyte derived, donor3	11389-118C3	20.45	24.51	9.04	0.52	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.15	9.56	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.57	7.13	0.79	0.48	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	13.20	7.09	0.42	0.97	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.17	8.37	1.40	0.60	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	9.56	9.27	0.58	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	3.99	2.49	0.00	0.25	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	17.63	54.91	25.76	1.36	3.39	2.71
Mast cell, donor1	11563-120D6	10.71	3.89	2.05	0.76	0.11	0.22
Mast cell, donor2	11565-120D8	16.94	53.49	24.67	1.49	1.78	6.84
Mast cell, donor3	11566-120D9	29.27	38.50	31.07	2.25	4.50	11.03
Mast cell, donor4	11567-120E1	27.83	35.99	21.10	1.95	1.42	9.22
Mast cell, expanded and stimulated, donor5	11940-126A5	16.41	4.99	5.77	0.55	0.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	23.35	3.50	7.00	1.17	0.58	1.75
Mast cell, expanded, donor5	11939-126A4	9.87	4.02	4.36	1.49	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	12.72	1.34	2.18	0.33	0.00	0.33
Melanocyte - dark, donor1	11502-119F8	13.33	3.88	2.59	1.29	0.50	0.90
Melanocyte - dark, donor2	11582-120F7	8.31	1.38	1.38	0.00	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	2.97	0.00	0.00	0.29	0.00	0.00
Melanocyte - light, donor1	11274-116H5	5.17	0.94	0.24	1.18	0.00	0.00
Melanocyte - light, donor2	11351-117H1	2.73	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	5.10	0.73	0.52	0.42	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.27	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	2.68	0.27	0.54	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	9.18	4.47	0.37	0.74	0.12	0.12
Meningeal Cells, donor2	11573-120E7	9.24	2.64	0.44	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	5.22	5.13	1.79	0.16	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	3.99	3.99	3.42	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	6.84	3.02	1.21	0.20	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	2.63	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	3.59	5.02	1.44	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	4.66	1.91	0.00	0.21	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	2.51	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2.42	2.42	0.44	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	5.84	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.07	1.84	0.61	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	4.29	1.11	0.00	0.14	0.42	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	2.97	1.12	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.74	3.82	2.11	0.66	0.53	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.37	0.89	0.30	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.92	1.92	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.67	7.09	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.26	3.75	1.88	0.00	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	5.81	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	10.08	7.42	3.18	0.00	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	8.51	9.51	2.50	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	8.74	10.19	3.11	0.29	0.29	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	41.86	16.20	8.10	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	24.38	28.08	12.07	0.25	0.74	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.31	12.37	7.07	1.77	1.18	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	17.29	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	29.44	10.54	0.62	0.62	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.13	13.90	5.19	0.41	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	20.84	6.95	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	24.78	15.02	1.00	1.00	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	14.90	18.62	11.64	0.47	0.00	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.40	23.17	12.60	0.81	0.81	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	13.46	7.13	1.19	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	17.10	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	22.12	10.62	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.08	11.78	7.60	0.38	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	11.84	11.84	2.63	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.95	23.34	11.25	0.00	1.06	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	6.45	1.84	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.43	21.46	9.54	0.00	0.60	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	8.38	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.78	22.58	11.04	0.75	0.50	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.46	24.00	11.41	0.48	0.71	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.03	17.14	9.95	0.55	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.45	32.23	10.36	0.69	0.23	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.99	27.55	10.31	1.47	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.54	27.31	9.99	0.20	0.61	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.01	27.46	15.66	0.43	0.64	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.78	28.90	11.34	0.00	0.22	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.88	40.08	14.24	0.66	0.44	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	28.39	11.66	1.52	0.00	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	23.20	11.60	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	10.60	39.41	14.95	0.82	0.54	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	37.64	13.23	0.59	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	20.72	8.72	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.84	30.76	4.81	0.48	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	32.42	10.81	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	9.60	2.74	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.51	24.53	8.01	0.00	1.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	8.15	4.08	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	17.95	6.13	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	11.04	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	12.81	4.48	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.21	16.86	6.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	11.13	2.09	0.70	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	6.63	6.63	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	12.31	7.52	0.00	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.50	9.63	5.25	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	4.26	4.26	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.33	14.31	7.57	0.28	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	7.90	2.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	8.16	3.50	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.73	14.18	6.33	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.93	9.60	6.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	13.85	10.16	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	14.23	4.55	1.14	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	10.78	10.09	7.19	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.18	17.62	8.03	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	14.16	5.15	1.29	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	14.61	11.43	5.72	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.87	16.55	6.94	0.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.86	18.86	4.79	0.30	1.20	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.02	8.48	6.64	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.33	14.65	9.87	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.95	15.92	7.30	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.17	9.10	9.48	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	14.21	9.94	1.14	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.83	15.49	8.36	0.25	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	4.56	8.47	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.06	10.88	10.29	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.57	24.80	10.67	0.00	0.58	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	17.72	13.19	0.82	2.06	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.55	16.08	9.53	0.30	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	22.60	15.07	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	44.56	8.91	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.76	32.20	19.71	0.66	1.31	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	18.94	10.52	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.18	55.35	23.72	0.59	1.38	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	15.83	16.76	4.66	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.14	35.30	14.65	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.26	16.78	8.52	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.08	28.73	11.08	0.68	0.45	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	23.58	12.52	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.56	30.78	19.05	0.73	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	20.22	9.33	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.77	19.77	5.34	0.53	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	11.59	11.59	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	18.18	12.12	1.01	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	12.23	6.75	1.26	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	35.41	5.45	1.36	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	7.63	2.54	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	8.10	2.43	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	6.04	3.02	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	131.33	22.84	0.00	0.00	34.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	61.99	3.26	0.00	3.26	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	23.76	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	50.20	50.20	0.00	12.55	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.77	3.66	0.43	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	3.66	0.52	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	2.00	3.34	1.33	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.43	4.17	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.99	5.51	0.00	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	6.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	2.72	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.35	0.42	0.84	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.95	2.56	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.59	2.43	0.54	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.10	2.73	0.84	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.47	0.99	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.06	1.35	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.76	1.81	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.41	2.94	0.98	0.00	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.75	3.46	0.91	0.00	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1.06	5.30	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.00	1.80	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.53	0.98	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.55	1.63	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.64	2.12	0.53	0.18	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	3.52	1.41	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	1.84	0.92	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3.21	2.57	1.29	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.31	1.72	0.34	0.34	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.81	3.34	0.45	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	2.12	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.41	1.66	0.47	0.00	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.15	3.43	0.43	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.00	2.67	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	1.35	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.57	3.57	0.79	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	1.86	0.93	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	2.27	0.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	1.63	0.33	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	1.74	0.44	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	3.17	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	3.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	2.66	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	1.98	1.98	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	2.68	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	1.81	0.60	0.30	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.06	4.20	1.11	0.22	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	3.39	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.10	1.83	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.29	2.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	1.51	0.30	0.61	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	2.37	1.58	0.79	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	2.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.21	5.96	1.61	0.50	0.25	0.12
Myoblast, donor2	11322-117D8	5.75	4.79	1.92	0.00	0.00	0.19
Myoblast, donor3	11398-118D3	4.54	8.41	1.35	0.17	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.09	0.44	0.29	1.02	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	42.74	6.46	3.69	0.92	1.54	5.23
Natural Killer Cells, donor2	11311-117C6	26.54	2.41	1.81	1.81	0.60	3.62
Natural Killer Cells, donor3	11387-118C1	40.49	7.91	2.02	1.29	0.74	2.76
Neural stem cells, donor1	11275-116H6	7.62	0.36	0.36	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	21.18	1.93	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	12.52	2.28	3.41	1.14	0.00	0.00
Neurons, donor2	11574-120E8	9.47	0.66	0.44	0.88	0.22	0.00
Neurons, donor3	11655-122E8	9.87	2.47	2.47	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	41.76	0.00	0.93	2.78	6.50	25.06
Neutrophils, donor2	11314-117C9	52.18	0.00	0.00	0.00	2.90	8.70
Neutrophils, donor3	11390-118C4	117.28	0.00	1.83	4.89	6.72	35.43
Nucleus Pulposus Cell, donor1	11252-116F1	7.60	1.66	2.02	0.47	1.66	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	2.93	1.95	0.33	0.65	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	5.21	0.20	0.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	5.92	4.68	0.83	0.28	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	6.51	7.38	1.74	0.14	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	9.19	10.67	2.04	0.34	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	13.73	4.68	0.97	0.29	0.97	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	12.64	11.43	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	3.19	2.13	0.21	0.21	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	3.43	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	3.72	0.62	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	2.35	1.56	0.00	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	5.62	2.11	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	7.11	4.98	1.78	0.36	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	9.69	4.30	0.59	0.76	0.84	0.08
Pericytes, donor1	11491-119E6	2.56	0.11	0.00	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	2.72	1.36	0.23	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	4.48	5.09	1.42	0.00	1.02	0.20
Perineurial Cells, donor1	11499-119F5	6.89	3.73	1.70	0.45	0.57	0.11
Perineurial Cells, donor2	11579-120F4	12.51	4.60	1.56	0.37	2.02	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	49.09	21.04	8.61	2.23	0.64	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	25.22	15.18	8.82	1.96	0.49	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	29.38	18.64	6.73	0.91	0.26	2.72
Placental Epithelial Cells, donor1	11278-116H9	3.83	4.30	0.00	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	5.54	8.87	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.14	8.44	0.59	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1.27	6.96	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	5.63	6.94	0.75	0.75	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.92	12.01	1.70	0.39	1.17	0.00
Preadipocyte - breast, donor2	11328-117E5	5.63	8.78	1.80	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	9.48	6.82	1.07	0.11	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	8.29	14.84	2.62	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	7.31	8.17	1.29	0.29	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	0.98	6.89	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	1.84	3.07	0.61	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	5.67	5.31	1.95	0.35	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	3.41	5.11	1.19	0.34	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	5.78	7.08	1.68	0.93	0.19	0.37
Preadipocyte - visceral, donor2	11357-117H7	5.98	5.52	0.92	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	3.03	4.28	0.52	0.63	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.50	8.15	0.60	1.06	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	6.91	3.25	0.68	0.41	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	3.98	2.08	0.24	0.00	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	9.34	7.86	1.03	0.46	0.68	0.57
Prostate Stromal Cells, donor2	11332-117E9	9.50	4.66	1.43	1.08	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	10.11	3.55	0.83	0.52	1.15	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	2.92	5.47	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	6.45	5.54	3.05	0.07	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	4.06	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.71	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	6.67	2.96	2.01	0.21	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	1.36	2.04	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.93	1.75	0.94	0.94	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.99	2.22	2.44	0.22	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	2.86	1.10	1.32	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	0.63	5.02	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.28	1.11	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	6.71	11.54	2.95	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	6.33	3.37	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	1.93	1.54	0.96	0.39	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	8.82	1.81	0.00	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.41	0.85	0.00	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4.52	0.00	0.50	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.70	16.17	5.88	1.34	4.14	3.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	1.79	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	2.20	0.55	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	10.44	4.64	0.00	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	19.37	2.99	0.39	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.44	2.68	1.39	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.16	5.35	1.23	0.67	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.65	2.85	0.74	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.74	2.56	1.28	0.47	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.41	4.62	1.39	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.54	2.33	0.14	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.89	2.12	0.91	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	16.13	5.91	0.72	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.46	4.45	0.00	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.91	4.08	0.86	0.43	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	10.18	4.87	0.44	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.09	3.63	0.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.99	2.42	1.40	0.37	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.09	4.51	1.69	0.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.00	5.18	0.80	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	8.66	5.65	1.07	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.08	2.67	1.15	0.76	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.57	3.74	0.85	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.13	4.48	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.28	4.10	1.37	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.58	3.65	0.36	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	7.60	4.05	1.10	0.86	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.13	4.57	1.34	0.67	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.96	4.95	0.24	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.74	6.15	1.19	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	9.35	4.68	1.17	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.75	3.73	0.21	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.30	3.54	1.33	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.70	4.60	1.04	0.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.71	4.98	0.40	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.58	3.41	1.19	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.00	3.66	1.16	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.66	3.44	0.17	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.85	3.98	0.82	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	15.27	5.42	1.48	0.49	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.71	1.53	0.17	0.68	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.73	2.37	1.78	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.33	4.26	1.07	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	9.54	0.97	0.14	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	8.33	2.38	0.71	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.53	3.63	0.60	0.40	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.44	1.88	0.09	0.00	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	9.78	2.45	0.70	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.97	3.02	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.22	1.71	0.37	0.12	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	25.91	4.95	0.87	1.16	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	11.56	2.43	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	10.55	2.41	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	13.12	3.17	0.23	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.07	3.89	0.60	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.93	2.95	0.24	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.74	1.28	0.64	0.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.64	2.40	1.20	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	3.57	0.19	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	3.40	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	4.16	3.51	2.19	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	4.93	2.19	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	2.76	3.22	1.38	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	3.30	1.24	0.00	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	19.88	16.57	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	8.47	5.65	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	6.25	1.23	0.44	0.18	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	9.40	2.17	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	3.34	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	5.34	5.34	0.94	0.79	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	7.13	5.80	2.23	0.00	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	5.69	6.62	2.00	0.31	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	9.07	4.28	2.27	0.63	1.64	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	6.28	5.14	3.28	0.14	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	9.72	6.35	2.58	0.50	0.00	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	4.63	2.70	1.10	0.42	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	1.45	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.48	1.51	0.28	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	42.98	8.06	2.69	0.00	5.37	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.18	2.59	0.72	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	10.63	0.00	0.00	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	3.38	5.06	0.26	0.26	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	10.43	5.42	1.39	0.28	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	9.28	5.77	0.98	0.28	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	56.03	17.76	4.86	3.59	0.21	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	10.49	4.57	0.52	0.30	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.25	1.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.89	5.78	0.22	0.00	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	2.35	2.35	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.07	3.31	0.44	0.22	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	2.76	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	1.55	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	0.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.26	0.67	0.53	0.13	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.09	3.10	0.44	0.22	0.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.60	3.97	0.90	0.00	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.81	1.95	0.65	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.81	4.73	0.89	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.25	2.99	1.85	0.00	0.57	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.28	1.79	0.98	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.13	3.04	0.30	0.00	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.56	2.27	1.26	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	2.38	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	3.54	4.28	0.74	0.15	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	4.52	2.80	0.65	0.65	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	5.25	3.36	0.73	0.31	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.56	2.47	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	3.29	1.49	0.00	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.15	2.39	0.68	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.08	1.18	0.79	1.10	1.18	1.88
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.84	6.44	1.81	0.10	0.50	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.01	5.46	2.50	0.23	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	1.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8.74	6.36	1.06	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.86	4.93	0.80	1.07	0.67	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.64	4.51	1.63	0.13	1.88	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.82	4.31	0.51	0.25	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.44	6.78	1.36	0.30	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	1.29	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	3.72	3.26	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	2.02	0.50	1.01	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	2.51	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	1.77	0.29	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	5.75	5.91	1.17	1.00	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	5.61	1.40	1.87	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	3.02	1.30	0.58	0.00	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	4.33	2.04	1.02	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.38	1.32	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	4.89	4.05	2.66	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.19	4.44	2.01	0.17	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.90	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.43	1.71	0.00	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.54	1.77	0.88	0.66	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	4.68	4.68	0.59	0.88	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.52	3.89	1.36	0.58	1.94	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.08	3.44	0.00	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.88	2.60	0.00	0.37	3.35	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.58	9.70	2.16	0.36	1.44	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.11	1.99	0.85	0.85	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.67	9.85	0.39	0.39	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	4.32	1.02	0.25	2.03	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	15.97	5.59	0.40	0.80	2.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	5.43	1.67	0.42	2.93	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	13.75	6.42	0.46	0.46	2.75	1.83
Synoviocyte, donor1	11291-117A4	5.89	11.45	4.04	0.67	0.50	0.50
Synoviocyte, donor2	11368-117I9	7.04	12.74	3.18	0.34	1.17	0.67
Synoviocyte, donor3	11440-118H9	10.50	8.27	0.89	0.45	1.12	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	4.29	1.07	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.01	0.69	0.23	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	7.31	4.87	0.22	0.36	0.00	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	1.55	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.72	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.32	15.13	6.27	2.34	4.55	2.83
Urethra, donor2	10319-105A4	64.74	3.60	1.80	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.66	1.86	0.80	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	3.20	1.60	0.80	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.35	2.98	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	8.25	7.58	1.56	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.94	4.45	0.00	0.89	2.67	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	51.47	2.86	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.80	4.11	0.68	2.74	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	38.91	3.10	2.41	2.07	2.07	5.85
Whole blood (ribopure), donor090325, donation2	12177-128I8	38.93	2.32	0.58	3.49	1.16	6.39
Whole blood (ribopure), donor090612, donation1	12182-129A4	41.65	2.08	0.00	3.12	1.04	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	4.59	0.92	5.51	0.00	5.51
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	3.65	3.65	1.83	2.74	3.65
Wilms' tumor cell line:G-401	10809-111A8	10.98	1.48	1.11	0.86	0.49	0.12
Wilms' tumor cell line:HFWT	10597-108E3	25.52	11.44	2.64	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	16.48	10.89	1.68	1.96	0.00	0.00
achilles tendon, donor2	10292-104G4	20.67	18.60	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.34	1.78	0.25	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.84	0.00	0.00	1.16	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.79	0.00	0.00	1.66	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7.07	0.00	0.00	1.90	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.37	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	8.04	3.17	4.65	1.06	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.70	0.54	1.91	0.54	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.24	0.00	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	9.80	0.00	0.00	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	10.87	0.39	0.78	1.16	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.68	0.00	0.00	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	0.00	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.01	5.81	6.51	1.86	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	8.54	0.52	1.29	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	6.72	1.17	0.58	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	8.83	5.11	2.79	0.46	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.87	0.41	1.65	1.65	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.53	0.61	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	3.84	0.43	0.00	0.85	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.34	0.30	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.85	0.24	0.72	0.72	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	4.23	0.00	0.22	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.68	1.33	1.67	1.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	76.19	33.45	7.43	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.35	20.72	7.53	1.51	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	24.42	0.00	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	3.75	3.75	5.62	3.75	3.75
adenocarcinoma cell line:IM95m	10796-110I4	28.02	15.54	2.12	1.18	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	21.87	12.72	5.12	2.33	0.93	1.55
adipose, donor1	10184-103D4	20.52	1.17	0.00	0.59	0.00	0.00
adipose, donor2	10185-103D5	6.89	0.41	0.00	1.62	0.00	0.00
adipose, donor3	10186-103D6	9.80	0.54	0.27	0.27	0.00	0.27
adipose, donor4	10187-103D7	23.40	0.00	0.87	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	21.31	1.10	2.84	3.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	22.15	107.13	10.14	0.80	0.00	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.72	1.07	1.07	1.07	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	42.43	18.78	1.85	1.85	0.00	1.39
amniotic membrane cells, donor2	12236-129G4	21.98	7.78	2.03	2.03	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	48.61	11.19	0.88	1.77	0.59	0.00
amygdala - adult, donor10196	10167-103B5	29.64	2.37	2.37	2.37	1.19	0.00
amygdala, adult, donor10252	10151-102I7	59.61	4.26	3.85	1.01	2.84	2.84
amygdala, newborn, donor10223	10360-105E9	18.72	4.52	2.26	0.65	2.26	2.26
anaplastic carcinoma cell line:8305C	10428-106D5	7.64	0.38	0.25	0.76	0.25	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.35	12.58	1.32	0.44	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.69	3.67	3.34	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	27.46	4.71	3.14	0.39	3.14	1.57
appendix, adult	10189-103D9	43.86	6.99	8.15	0.78	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.16	0.34	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	21.74	5.43	2.72	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	28.10	2.90	1.30	0.43	0.72	0.58
b cell line:RPMI1788	10427-106D4	10.56	8.62	3.87	0.59	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.37	11.65	2.22	0.28	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.69	19.55	2.58	0.79	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	9.21	10.04	1.34	0.67	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.68	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	36.39	3.91	1.63	2.28	1.74	1.09
blood, adult, pool1	10053-101G8	24.36	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	12.85	0.00	0.86	0.86	0.00
bone marrow, adult	10192-103E3	19.57	12.82	6.75	2.02	2.70	0.67
brain, adult, donor1	10084-102B3	28.70	10.25	4.10	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	27.73	8.02	5.23	1.67	1.89	0.78
brain, fetal, pool1	10085-102B4	32.06	2.67	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	42.62	15.86	3.96	1.65	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	29.58	1.50	1.62	1.37	0.25	0.12
breast, adult, donor1	10080-102A8	22.73	10.73	5.05	1.26	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.70	9.78	0.89	2.03	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	5.26	4.95	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.91	0.46	0.69	0.92	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	0.48	0.00	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	9.40	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	28.99	1.31	0.66	0.66	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	7.29	0.00	0.32	1.90	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	17.57	1.06	1.06	0.53	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	61.02	1.15	3.45	1.15	2.30	4.61
caudate nucleus, adult, donor10252	10164-103B2	61.74	4.02	3.68	2.01	3.01	2.34
caudate nucleus, adult, donor10258	10379-105H1	46.61	6.11	1.53	1.53	3.06	2.29
caudate nucleus, newborn, donor10223	10354-105E3	30.40	3.30	2.56	0.73	3.30	2.20
cerebellum - adult, donor10196	10173-103C2	72.83	0.00	0.00	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	82.20	4.27	2.14	2.56	2.35	0.64
cerebellum, adult, pool1	10083-102B2	31.39	4.83	1.38	0.34	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	81.37	6.64	2.49	0.83	4.98	0.83
cerebral meninges, adult	10188-103D8	35.05	4.54	1.01	2.02	3.28	1.01
cerebrospinal fluid, donor2	10294-104G6	27.04	6.58	2.19	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.64	19.12	4.31	0.86	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	11.60	14.42	1.66	0.50	0.50	0.66
cervix, adult, pool1	10013-101C4	45.46	9.97	5.25	2.20	4.83	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.77	13.10	2.23	0.84	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	1.31	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	10.69	10.07	3.11	1.74	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	7.27	18.24	4.93	1.11	0.12	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	13.28	5.22	0.00	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	11.97	21.37	1.71	0.28	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	8.75	8.15	1.19	0.50	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	10.44	25.83	1.65	0.55	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	7.30	2.31	1.34	0.58	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	24.08	29.78	7.81	1.90	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.99	37.75	11.30	4.62	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.36	48.38	13.79	4.60	0.97	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	30.13	40.93	11.40	2.24	1.43	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	50.06	82.45	9.13	5.30	2.65	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	27.63	40.14	15.90	1.30	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.49	1.14	0.23	0.46	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	9.37	16.83	3.47	1.04	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	16.47	9.52	3.29	1.28	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	14.44	0.00	0.38	1.52	0.00	0.00
colon, adult, donor1	10082-102B1	27.37	1.19	3.57	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	30.55	19.27	5.52	1.53	1.18	1.53
colon, fetal, donor1	10070-101I7	22.25	4.94	2.47	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	220.01	0.00	9.17	22.92	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	39.09	49.72	8.92	2.12	1.27	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.07	45.88	8.00	1.96	0.60	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	33.84	58.52	9.87	1.55	1.69	1.97
corpus callosum, adult, pool1	10042-101F6	86.13	21.12	12.94	4.31	7.41	2.43
cruciate ligament, donor2	10295-104G7	29.18	21.07	3.24	0.00	4.05	0.81
diaphragm, fetal, donor1	10069-101I6	31.30	2.41	2.41	0.80	2.41	0.80
diencephalon, adult	10193-103E4	27.36	8.88	2.64	0.96	2.88	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.63	0.23	0.69	0.46	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	3.59	8.21	1.54	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.63	0.00	0.00	0.24	0.24	0.00
ductus deferens, adult	10196-103E7	33.89	2.99	1.50	1.50	2.49	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	7.20	2.88	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	46.35	10.30	2.94	1.47	2.94	2.21
dura mater, adult, donor1	10041-101F5	20.48	14.78	6.85	1.07	4.79	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	17.99	4.66	4.22	0.22	1.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.04	5.73	4.01	0.00	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	8.02	0.00	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	7.87	0.00	0.00	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.88	0.00	0.00	1.23	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	42.91	48.60	10.73	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	21.39	15.04	3.62	1.63	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.35	9.97	4.18	0.32	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	15.45	15.67	1.11	0.78	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	5.50	18.59	1.87	0.55	0.00	0.00
epididymis, adult	10197-103E8	26.16	10.05	7.54	0.63	2.72	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.14	20.76	6.56	0.71	0.53	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.80	1.57	1.18	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	8.65	18.22	2.75	0.66	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	7.09	23.82	3.94	1.18	0.20	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	7.73	17.59	4.37	0.34	0.00	0.00
esophagus, adult, pool1	10015-101C6	27.71	7.43	1.81	1.27	1.27	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	22.04	2.00	1.25	1.75	0.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	33.80	4.83	2.41	0.00	2.41	4.83
eye - muscle lateral, donor2	10298-104H1	37.88	8.42	0.00	0.00	6.31	2.10
eye - muscle medial, donor2	10299-104H2	52.09	4.46	0.00	1.49	7.44	0.00
eye - muscle superior, donor2	10297-104G9	36.69	9.17	4.59	1.15	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	33.52	8.74	2.91	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	29.49	6.86	1.78	1.78	1.02	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	7.44	2.31	0.64	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.35	2.37	1.19	1.19	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	47.38	9.19	3.19	1.78	3.47	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	11.11	4.20	1.80	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.89	9.51	4.21	0.55	0.09	0.09
gall bladder, adult	10198-103E9	32.83	7.24	2.17	1.45	1.21	1.45
gamma delta positive T cells, donor1	11937-126A2	34.36	0.54	0.00	0.54	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	32.87	0.37	0.00	0.75	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.14	1.69	0.00	0.63	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	16.25	0.19	0.00	0.58	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	15.90	8.36	2.79	1.97	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	14.64	13.73	1.83	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	26.73	0.00	0.00	0.69	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	8.26	2.64	0.23	0.57	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	7.42	3.36	0.14	0.56	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.72	10.23	1.75	1.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	4.01	1.79	0.74	0.63	0.11	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	5.90	1.69	0.56	0.28	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	5.30	1.88	0.22	0.99	0.22	0.22
glioma cell line:GI-1	10413-106B8	7.61	0.00	0.29	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	69.98	15.31	5.83	3.64	8.75	0.73
globus pallidus, adult, donor10252	10161-103A8	85.19	20.26	16.84	2.93	2.93	1.71
globus pallidus, adult, donor10258	10367-105F7	60.25	8.22	6.85	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	27.71	7.99	4.80	1.60	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	119.91	12.24	2.45	9.79	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.16	5.12	2.56	0.00	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	19.74	1.38	0.00	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	14.18	0.91	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	15.46	0.64	0.00	1.29	0.64	0.64
hIPS, biol_rep1	14380-156B6	17.25	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	14.40	0.00	0.00	0.69	0.00	0.69
hIPS, biol_rep3	14382-156B8	36.41	2.21	0.00	2.21	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	6.32	9.48	2.01	0.29	0.00	0.86
heart - mitral valve, adult	10205-103F7	36.47	9.57	2.99	0.90	6.88	1.49
heart - pulmonic valve, adult	10206-103F8	32.68	7.32	2.88	0.78	2.35	1.83
heart - tricuspid valve, adult	10207-103F9	44.96	11.66	2.50	3.33	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	13.47	3.88	2.24	0.82	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	23.42	3.41	1.70	0.00	0.85	0.43
heart, adult, pool1	10016-101C7	41.86	5.29	1.84	2.07	0.92	1.15
heart, fetal, pool1	10046-101G1	55.55	3.80	2.77	1.44	4.11	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.34	3.39	0.62	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	60.65	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	17.02	0.77	0.44	0.44	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	14.08	0.97	0.49	1.09	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	15.36	0.71	1.01	1.11	0.00	0.30
hepatoma cell line:Li-7	10484-107A7	12.23	0.44	0.33	0.56	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.86	28.74	6.63	0.20	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	51.10	4.73	2.84	2.84	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	69.39	9.18	6.12	2.45	3.06	2.65
hippocampus, adult, donor10258	10374-105G5	36.85	4.48	1.00	1.99	1.00	1.00
hippocampus, newborn, donor10223	10363-105F3	23.62	3.52	2.11	1.06	2.11	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	1.22	0.61	4.88	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.33	0.98	0.79	0.59	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	14.47	2.54	0.25	1.52	0.51	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.68	0.00	0.77	0.77	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.83	0.38	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	9.05	0.58	0.00	0.88	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	7.76	0.65	0.22	0.86	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	7.92	0.83	0.00	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.55	1.42	0.47	0.71	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	6.43	0.96	0.64	0.48	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.12	3.37	1.35	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.18	1.88	0.94	1.41	0.16	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.74	0.98	1.47	0.98	0.98	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	2.62	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.59	0.00	0.00	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.41	0.44	0.00	1.74	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	8.00	0.50	0.00	1.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.09	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.28	0.00	0.91	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.70	0.00	0.00	0.31	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.72	0.49	0.33	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	5.23	0.29	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	5.98	0.30	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.52	0.74	0.37	2.22	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.41	0.86	0.29	1.43	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	21.64	0.82	0.00	0.82	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.39	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.97	0.95	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.75	0.30	0.30	0.61	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	6.21	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	10.63	0.66	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.18	0.51	0.26	0.51	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.67	0.77	0.26	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	0.76	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.39	1.01	0.00	1.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.43	0.72	0.24	1.93	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	0.00	0.00	0.45	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.73	0.49	0.00	1.95	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.58	0.00	0.00	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	5.96	0.33	0.00	1.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	4.93	0.00	0.00	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.96	0.72	0.00	1.09	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	0.71	0.00	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	12.46	0.68	0.00	0.68	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.47	1.62	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	21.55	51.58	16.47	1.94	1.70	4.60
immature langerhans cells, donor2	11905-125F6	29.31	124.36	38.02	0.79	1.58	7.92
insula, adult, pool1	10039-101F3	49.68	8.61	3.79	1.99	3.03	2.65
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	2.93	0.33	0.33	0.00	0.65
kidney, adult, pool1	10017-101C8	27.74	11.31	8.81	1.40	1.00	1.70
kidney, fetal, pool1	10045-101F9	45.55	14.78	11.25	1.41	2.19	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.30	8.95	2.13	1.42	0.85	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.75	1.80	0.28	0.97	0.69	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	7.71	20.18	1.10	0.92	0.00	0.18
left atrium, adult, donor1	10079-102A7	17.98	3.81	3.81	0.54	1.09	0.54
left ventricle, adult, donor1	10078-102A6	12.14	3.03	1.01	0.00	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	13.13	8.76	3.01	1.37	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	4.67	2.16	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	2.72	1.63	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	4.13	2.19	2.67	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	3.14	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.81	22.67	5.90	0.59	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	8.28	1.41	0.31	0.47	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	6.34	2.07	1.34	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	23.99	5.51	0.97	0.49	0.65	1.46
liver, fetal, pool1	10086-102B5	16.93	20.70	7.53	0.94	0.00	3.76
locus coeruleus - adult, donor10196	10182-103D2	56.29	12.83	7.29	2.19	3.79	1.17
locus coeruleus, adult, donor10252	10165-103B3	62.01	11.63	9.97	3.32	2.95	0.37
locus coeruleus, adult, donor10258	10375-105G6	19.75	6.49	4.80	1.13	1.13	0.85
locus coeruleus, newborn, donor10223	10362-105F2	25.24	2.52	1.26	1.68	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	17.16	3.18	0.69	1.52	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	2.07	0.69	2.07	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	19.90	20.30	3.30	1.45	0.26	0.40
lung, adult, pool1	10019-101D1	37.09	21.85	5.79	2.72	1.06	0.95
lung, fetal, donor1	10068-101I5	89.05	21.69	4.28	3.14	7.42	2.28
lung, right lower lobe, adult, donor1	10075-102A3	31.16	24.29	8.71	1.37	2.75	1.83
lymph node, adult, donor1	10077-102A5	22.72	6.63	4.26	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.48	3.07	0.88	0.44	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.22	0.15	0.45	0.30	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	38.23	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	27.97	15.10	6.66	1.78	0.44	1.33
mature adipocyte, donor2	12232-129F9	21.79	13.90	6.02	0.62	0.62	1.04
mature adipocyte, donor3	12233-129G1	18.25	22.05	6.64	0.47	0.71	0.24
mature adipocyte, donor4	12234-129G2	28.69	9.21	4.47	0.26	2.11	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.26	3.81	0.95	1.19	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	38.35	2.26	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	54.80	4.97	5.52	1.47	2.57	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	32.09	2.86	0.32	0.95	1.59	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	29.00	4.69	0.00	0.43	2.13	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	53.33	3.88	1.52	1.86	2.36	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	65.58	8.91	6.37	1.49	3.61	2.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	1.93	0.00	0.00	7.71	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	28.71	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	24.41	3.95	2.15	0.72	2.87	1.08
medulla oblongata - adult, donor10196	10174-103C3	64.90	11.03	7.79	1.95	5.84	3.89
medulla oblongata, adult, donor10252	10155-103A2	63.47	13.16	11.15	3.41	3.25	4.18
medulla oblongata, adult, pool1	10038-101F2	56.57	18.61	7.84	1.88	6.12	1.06
medulla oblongata, newborn, donor10223	10361-105F1	24.65	4.86	4.17	1.04	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	25.24	0.22	0.22	3.10	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	12.84	0.61	0.61	1.10	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	4.60	0.14	0.14	0.14	0.00	0.00
melanoma cell line:G-361	10465-106H6	2.71	0.54	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	11.22	1.45	0.36	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	0.88	3.52	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	7.00	0.00	0.00	0.26	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	6.14	4.91	1.23	0.31	0.61	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	6.36	2.91	0.00	0.55	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.11	2.90	0.00	0.41	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	11.52	3.37	0.42	0.14	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	3.66	0.77	0.39	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	3.47	0.00	0.69	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.16	0.86	0.00	0.69	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.49	4.14	1.04	0.35	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.76	4.64	0.27	0.40	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.59	5.67	0.54	0.27	0.27	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.66	4.27	0.28	0.43	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	0.99	0.99	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.61	2.21	1.52	0.42	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.93	7.33	0.70	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.76	1.84	0.20	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.39	1.44	1.08	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.24	3.00	1.34	0.31	0.21	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.56	6.61	1.60	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.97	7.55	0.84	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.87	2.24	0.60	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.35	4.29	1.40	0.18	0.09	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.47	2.58	0.00	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.30	4.29	1.72	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.63	10.95	2.11	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	4.57	7.31	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	4.35	7.42	1.02	0.26	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.54	7.59	0.79	0.00	1.31	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.24	6.16	1.85	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.30	7.30	1.18	0.24	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.45	7.45	1.02	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	3.93	1.18	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.02	6.95	0.00	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.65	9.52	2.02	0.87	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.81	6.25	1.56	0.00	1.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	7.21	5.53	0.96	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	10.27	2.20	1.47	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	6.38	2.01	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	6.14	0.82	0.41	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.58	6.87	0.43	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	5.47	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.44	7.47	0.97	0.00	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	11.64	1.45	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	5.33	0.00	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	8.18	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.83	7.00	2.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	4.20	6.30	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	4.97	14.90	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	14.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	4.74	8.89	1.19	0.59	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	9.75	3.66	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	12.03	1.27	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.04	5.86	0.69	1.38	3.10	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	6.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.70	0.81	0.81	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	0.79	1.59	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.13	0.59	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.43	0.31	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	2.07	2.75	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	3.96	0.49	1.48	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	1.12	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	1.27	0.64	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	1.61	0.81	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.89	3.64	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	0.00	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.16	5.75	0.00	0.60	1.39	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.79	3.57	0.65	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	2.04	1.02	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	8.51	0.00	0.77	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	20.32	16.54	1.89	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.49	6.95	1.62	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.09	5.45	0.51	0.41	0.00	0.31
mesothelioma cell line:Mero-25	10850-111F4	6.58	0.68	0.68	0.23	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	5.62	6.85	1.47	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	6.64	4.21	2.44	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	5.26	2.10	0.53	0.79	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	3.57	1.19	0.00	0.34	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	7.33	11.63	2.78	0.25	0.51	0.51
mesothelioma cell line:Mero-95	10856-111G1	7.04	3.73	0.41	0.00	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	5.47	7.79	0.83	0.00	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	11.76	6.70	1.63	0.36	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	11.79	6.15	1.02	0.51	0.51	1.37
mesothelioma cell line:NCI-H28	10845-111E8	7.89	0.76	1.02	0.00	0.00	0.00
mesothelioma cell line:No36	10857-111G2	6.85	7.83	1.63	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	8.67	2.98	0.54	0.00	0.00	0.81
migratory langerhans cells, donor1	11901-125F2	3.84	10.17	2.30	0.58	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	7.45	10.14	2.93	0.24	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	11.67	10.59	4.85	0.00	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.92	0.33	0.00	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.93	5.09	2.33	0.64	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.28	23.27	1.38	1.15	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.51	23.41	3.81	0.00	0.38	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	25.69	0.00	0.18	2.40	0.00	0.18
myeloma cell line:PCM6	10474-106I6	11.86	7.51	2.17	0.40	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	12.17	9.13	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	11.57	3.14	0.98	0.59	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.58	1.89	0.22	0.45	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.06	1.32	0.29	0.29	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	12.70	1.66	1.10	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	27.38	0.00	0.00	1.61	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	18.71	0.37	0.19	0.94	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	10.97	0.00	0.00	0.84	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	14.91	0.00	0.00	1.30	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.07	0.00	0.24	0.95	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.08	0.95	0.95	0.32	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	8.65	0.00	0.20	0.60	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.91	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	11.71	10.38	0.53	0.80	0.27	0.27
neutrophil PMN, donor1	12133-128D9	193.37	0.00	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	57.50	0.00	0.00	5.75	0.34	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	0.00	0.00	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	5.77	5.77	0.32	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	3.15	4.73	0.79	0.00	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	62.34	10.50	4.12	2.91	4.41	1.12
occipital cortex - adult, donor10196	10172-103C1	43.27	6.18	4.12	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	81.85	9.12	6.71	2.68	1.61	1.61
occipital cortex, newborn, donor10223	10355-105E4	20.02	7.64	1.82	0.73	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	34.37	9.71	4.72	1.84	2.36	1.05
occipital lobe, fetal, donor1	10073-102A1	42.48	2.15	0.86	1.72	1.29	0.00
occipital pole, adult, pool1	10036-101E9	30.51	6.15	2.60	1.50	1.26	0.79
olfactory region, adult	10195-103E6	37.83	5.54	2.48	2.10	1.34	0.57
optic nerve, donor1	10277-104E7	134.07	40.02	22.01	4.00	12.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	61.40	20.96	1.71	1.82	0.68	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.66	13.60	2.47	0.55	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.80	11.18	1.35	1.19	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.62	1.39	0.12	0.23	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	9.99	9.70	0.88	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	8.41	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	11.03	3.39	0.85	0.42	0.21	0.00
ovary, adult, pool1	10020-101D2	38.26	3.41	1.75	2.45	3.58	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	7.33	0.73	0.18	0.73	0.00	0.00
pancreas, adult, donor1	10049-101G4	47.03	2.82	1.88	0.00	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	3.91	1.40	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	7.50	2.38	0.00	0.68	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.86	22.85	4.14	1.66	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	49.06	10.62	4.94	2.38	3.39	1.01
parietal cortex, adult, donor10258	10373-105G4	32.30	2.94	0.73	1.47	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	52.67	12.23	3.76	2.82	2.82	0.94
parietal lobe, adult, donor10252	10157-103A4	60.71	6.27	4.85	1.14	2.57	0.00
parietal lobe, adult, pool1	10034-101E7	50.05	11.72	5.46	2.29	3.26	1.85
parietal lobe, fetal, donor1	10072-101I9	55.28	1.94	0.97	3.88	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	22.43	6.73	1.87	0.75	1.87	1.12
parotid gland, adult	10199-103F1	31.45	1.85	0.62	0.00	1.85	1.23
penis, adult	10200-103F2	26.32	11.82	5.37	0.54	2.69	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.75	3.90	3.53	2.79	0.37	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.20	6.41	0.73	0.29	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	130.94	3.23	2.58	1.29	7.74	5.16
pineal gland, adult, donor10252	10160-103A7	185.36	5.33	1.18	4.74	4.15	8.29
pineal gland, adult, donor10258	10377-105G8	70.86	3.76	0.00	4.39	5.64	2.51
pituitary gland - adult, donor10196	10180-103C9	56.66	3.04	0.00	1.01	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	121.43	1.04	1.04	2.61	1.04	4.17
pituitary gland, adult, donor10258	10378-105G9	40.01	0.85	0.00	1.70	2.55	1.70
placenta, adult, pool1	10021-101D3	27.31	11.61	4.30	0.97	1.18	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	5.30	0.00	0.13	0.26	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.28	1.40	0.62	0.62	0.62	0.47
pons, adult, pool1	10033-101E6	40.11	11.36	6.20	1.72	5.16	1.03
postcentral gyrus, adult, pool1	10032-101E5	36.09	8.89	3.92	1.66	3.05	1.05
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	2.09	0.00	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	11.65	12.09	2.91	2.18	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	66.97	0.00	0.00	3.99	0.18	0.00
prostate, adult, pool1	10022-101D4	41.08	4.90	2.72	1.72	3.08	1.27
putamen, adult, donor10196	10176-103C5	58.54	4.01	1.89	3.07	2.12	0.94
putamen, adult, donor10252	10152-102I8	86.27	1.96	1.96	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	1.09	0.00	1.09	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	35.76	5.32	1.93	2.42	2.42	1.21
putamen, newborn, donor10223	10365-105F5	17.99	4.50	3.75	0.00	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	45.09	11.35	0.58	0.87	0.00	0.58
rectum, fetal, donor1	10067-101I4	43.12	4.17	2.78	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	10.39	2.76	1.48	0.42	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.15	0.00	0.00	2.07	0.00	0.41
retina, adult, pool1	10030-101E3	51.09	4.47	2.48	3.08	7.26	4.87
retinoblastoma cell line:Y79	10475-106I7	21.30	0.00	0.00	2.86	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.05	0.61	0.86	0.61	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.59	0.00	0.00	1.41	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	2.27	1.52	1.52	1.52	0.00
salivary acinar cells, donor1	11771-123I7	15.54	10.36	1.46	1.29	1.13	0.49
salivary acinar cells, donor2	11772-123I8	17.49	8.54	1.51	0.55	0.28	0.96
salivary acinar cells, donor3	11773-123I9	55.61	14.57	2.65	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	59.48	2.86	0.57	1.72	2.29	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.85	4.22	1.77	0.59	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.11	2.59	1.53	0.24	0.12	0.12
seminal vesicle, adult	10201-103F3	43.91	3.70	4.23	0.53	2.65	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.10	7.04	1.46	0.73	0.00	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.03	4.78	1.26	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	9.03	3.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	7.66	1.07	0.27	0.13	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	8.29	2.21	0.00	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	7.61	0.26	0.00	0.39	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	0.00	0.00	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	27.83	5.40	2.04	0.96	0.84	0.36
skeletal muscle, fetal, donor1	10066-101I3	19.10	8.04	3.02	0.00	4.02	0.00
skin, adult, donor1	10074-102A2	20.36	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	54.29	23.99	8.21	3.79	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	7.67	0.00	0.00	0.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	15.76	0.00	0.32	0.63	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	28.33	0.19	1.16	3.28	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	4.78	7.91	0.82	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	11.42	0.00	0.16	0.80	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	7.85	0.00	0.00	0.22	0.00	0.00
small intestine, adult, pool1	10024-101D6	39.18	21.50	6.33	1.43	0.48	0.72
small intestine, fetal, donor1	10064-101I1	24.32	5.41	2.21	1.47	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	9.75	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	35.15	8.01	3.88	0.78	4.91	0.78
somatostatinoma cell line:QGP-1	10781-110G7	28.95	0.00	0.00	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	64.46	20.42	16.98	1.84	4.82	2.29
spinal cord, adult, donor10252	10159-103A6	75.31	13.80	11.83	1.58	2.37	1.97
spinal cord, adult, donor10258	10369-105F9	37.36	10.38	2.77	0.00	4.15	2.08
spinal cord, fetal, donor1	10056-101H2	50.01	5.49	3.05	1.83	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	55.11	6.43	3.67	1.38	5.05	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	8.07	8.66	1.05	0.45	0.15	0.00
spleen, adult, pool1	10025-101D7	34.80	6.17	3.41	1.21	0.11	0.66
spleen, fetal, pool1	10044-101F8	45.13	6.52	3.42	2.38	2.62	3.10
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.57	83.53	30.12	1.66	0.31	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.01	15.00	2.09	0.57	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.98	6.64	5.24	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.65	1.95	0.78	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.67	18.57	1.69	0.34	0.00	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	6.35	0.42	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.50	14.81	2.12	0.00	0.42	1.27
stomach, fetal, donor1	10062-101H8	34.18	5.34	2.14	2.14	1.07	1.07
submaxillary gland, adult	10202-103F4	44.44	3.42	1.14	1.14	1.14	2.28
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	73.32	19.94	17.45	3.74	2.49	2.08
substantia nigra, adult, donor10258	10371-105G2	28.97	5.17	1.03	0.52	1.55	1.03
substantia nigra, newborn, donor10223	10358-105E7	45.22	7.07	2.83	0.71	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	32.33	3.21	6.19	3.67	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	34.67	5.59	3.56	1.44	1.86	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.89	2.14	0.00	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	34.72	0.88	1.32	0.88	0.00	0.44
tenocyte, donor1	11763-123H8	6.98	13.96	2.09	1.05	0.70	0.70
tenocyte, donor2	11765-123I1	7.63	14.88	2.67	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	7.41	8.15	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.09	4.08	1.02	0.68	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	12.18	2.00	0.31	1.54	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	13.17	3.56	1.70	0.77	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.16	9.14	1.90	0.63	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.19	2.65	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.43	1.85	0.22	0.11	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.23	3.58	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	26.20	4.83	3.01	1.61	2.36	3.01
testis, adult, pool2	10096-102C6	35.64	1.80	1.35	1.80	4.06	0.90
thalamus - adult, donor10196	10168-103B6	91.63	17.66	3.31	1.10	6.62	3.31
thalamus, adult, donor10252	10154-103A1	87.52	16.10	14.53	1.41	2.50	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	0.00	1.54	1.54	6.16	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.90	7.08	2.80	0.66	1.15	0.99
thalamus, newborn, donor10223	10366-105F6	20.14	0.58	0.00	1.15	1.15	1.15
throat, adult	10209-103G2	24.97	8.99	3.25	1.50	0.75	2.00
throat, fetal, donor1	10061-101H7	56.98	5.79	5.18	3.35	2.74	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	6.96	0.20	0.79	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	31.22	3.18	1.29	3.08	0.50	3.48
thymus, fetal, pool1	10043-101F7	67.64	3.01	1.66	4.68	1.87	2.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.38	3.86	0.80	0.53	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	7.54	7.68	1.12	0.56	0.14	0.00
thyroid, adult, pool1	10028-101E1	51.70	4.39	1.68	2.15	1.49	3.45
thyroid, fetal, donor1	10060-101H6	68.29	4.48	1.58	1.58	2.37	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	6.16	0.00	0.00	9.24	3.08
tongue, adult	10203-103F5	21.40	8.37	2.09	0.47	1.40	0.93
tongue, fetal, donor1	10059-101H5	23.25	2.76	0.79	0.79	0.39	0.79
tonsil, adult, pool1	10047-101G2	47.38	8.31	3.31	2.40	1.50	1.50
trachea, adult, pool1	10029-101E2	37.05	14.23	2.78	1.55	0.90	2.04
trachea, fetal, donor1	10058-101H4	33.47	12.31	2.69	1.54	4.23	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.09	7.09	1.06	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	9.12	12.66	1.93	0.30	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.85	12.53	1.25	1.41	0.31	0.16
tridermal teratoma cell line:HGRT	10694-109G1	13.32	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.63	0.85	0.00	0.34	0.08	0.25
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	2.09	0.00	8.35	0.00
uterus, adult, pool1	10100-102D1	40.27	8.87	3.24	2.05	4.44	2.73
uterus, fetal, donor1	10055-101H1	30.20	11.26	6.66	0.51	1.54	0.00
vagina, adult	10204-103F6	49.11	7.11	0.65	1.29	1.94	4.52
vein, adult	10191-103E2	23.89	6.58	1.97	1.10	2.19	2.41
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.14	9.61	3.20	0.00	0.00	0.00